Israel Makov

Rediff.com » News » Israel Makov

News for Israel Makov

Business

Sun Pharma, Mahindras in India's top-10 club

In May 2012, when Dilip Shanghvi announced he was relinquishing his job as chairman of Sun Pharmaceuticals to make way for Israel Makov, former CEO of Teva Pharmaceuticals, everyone wondered why......

We will regain confidence of the US FDA: Dilip Shanghvi

As it announced the beginning of its integration with Ranbaxy, Dilip Shanghvi, Sun Pharmaceuticals’ managing director, spoke to Abhineet Kumar and Reghu Balakrishnan about challenges and......

Sun Pharma to delist Ranbaxy on completion of $4-bn merger

Sun Pharmaceutical on Wednesday said Ranbaxy will be delisted from the Indian bourses following the completion of their $4-billion merger. "Following the closure of this transaction, Ranbaxy will......

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

It will take a ‘few years’ for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a ‘complex......

Sun chief hopes the worst is over for Ranbaxy

Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company Chairman Israel Makov said. Sun Pharma's......

Rediff News

Israel Makov

News for Israel Makov

Sun Pharma, Mahindras in India's top-10 club

We will regain confidence of the US FDA: Dilip Shanghvi

Sun Pharma to delist Ranbaxy on completion of $4-bn merger

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

Sun chief hopes the worst is over for Ranbaxy

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS